Previous studies have shown that somatic mutations in tumor-associated genes (EGFR, IDH1, TP53, NF1, and etc.,) and large regions of CNVs were regarded as major roles in tumorigenesis and the development of glioma [33,34,35]. The gene discussed is TP53; the disease is glioma.